Tissue factor (TF) expression has also been shown to contribute to VTE risk in malignancy [12], and interestingly, persistently elevated levels of TF have been observed in MM patents following chemotherapy who subsequently developed a thrombosis [13]. Here, TF is linked to Venous thrombosis.